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Vulnerable Plaque Inside Stent
Jin-Man Cho, MD, PHD,* Il-Suk Sohn, MD, PHD,* Chong-Jin Kim, MD, PHD,*
k-Kyung Jang, MD, PHD†
I T HAS BEEN PROPOSED THAT NONHEAL ING ENDOTHEL IUM after percuta-
eous coronary intervention may allow for insudation of lipids superﬁcial to the stent strut level,
specially when the underlying plaque carried a large necrotic core. This may result in formation of a
ipid-rich neointima, and the lipid core so created is referred to as nouveau atherosclerosis; the
eointimal lipid accumulation is physically not connected to the original (pre-interventional) lipid core
1). The likelihood of development of nouveau atherosclerosis is substantially enhanced in the presence
f drug-eluting stents, which further delay the endothelial healing. Furthermore, new atherosclerosis
ccurs much earlier in drug-eluting stent–based percutaneous coronary intervention compared to
are-metal stent–based interventions. Since endothelial lining is not mature over these atherosclerotic
ipid cores, evolving ﬁbrous caps remain predominantly attenuated (1,2). Thin ﬁbrous caps are
usceptible to rupture and may contribute to possible late stent thrombosis. Although tacitly believed,
n actual plaque rupture has not been documented in such a setting.
Figure 1. Coronary Angiograms of Left Coronary Artery
Coronary angiogram of the left coronary artery on the anteroposterior (A) and left anterior oblique (B) view with cranial angulation.
A mild focal in-stent restenosis with some intraluminal haziness is visualized in the distal left anterior descending (arrow). Also see
Online Video 1.
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431A 74-year-old man with a history of sirolimus-eluting stent (Cypher, Cordis Corp., Miami Lakes, Florida)
placement for an acute myocardial infarction 2 years prior presented to the emergency department
with new onset chest pain and diaphoresis. Electrocardiogram showed new anterior wall changes. His
serum creatine kinase-MB and Troponin I were elevated at 7.0 ng/ml and 2.39 ng/ml, respectively. He
underwent coronary angiography, which revealed a focal hazy area (Fig. 1, white arrow) inside the stent
(Online Video 1). Optical coherence tomography (LightLab Imaging, Westford, Massachusetts) of the lesion
demonstrated a large, empty space covered by a thin layer (80 m) (Fig. 2, Online Video 2). The membrane
as disrupted at one focal area (Fig. 2, white arrow) with some residual material inside the space: the
eatures that are similar to “thin cap ﬁbroatheroma.”
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Figure 2. OCT of the Culprit Lesion in the LAD
Sequential optical coherence tomography (OCT) images of the distal left anterior descending (LAD) in-stent restenosis lesion demonstrate a large empty space
with intact layer on the luminal side with high signal inside of the stent (A). The layer becomes thinner proximally and ruptured into the lumen (arrow, B). The
morphology is similar to that of ruptured vulnerable plaque. A lipid-rich plaque with a thin ﬁbrous cap has developed inside the stent, which was disrupted with
extrusion of thrombogenic substrates leading to occlusive thrombus formation. The “vulnerable plaque” inside a stent may be one possible mechanism for very
late stent thrombosis. Also see Online Video 2.2R E F E R E N C E S
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